Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.
Denis NashAvantika SrivastavaJenny ShenKate PenroseSarah Gorrell KulkarniRebecca ZimbaWilliam YouAmanda BerryChloe MirzayiAndrew MarokoAngela M ParcesepeChristian GrovMcKaylee M RobertsonPublished in: medRxiv : the preprint server for health sciences (2023)
The work was supported by the CUNY Institute for Implementation Science in Population Health, the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), Pfizer, Inc., and the U.S. National Institute of Mental Health (NIMH).